tradingkey.logo
tradingkey.logo
검색

Sonoma Pharmaceuticals Inc

SNOA
관심 목록에 추가
1.210USD
0.0000.00%
종가 07/02, 13:00ET시세는 15분 지연됩니다
2.09M시가총액
손실P/E TTM

Sonoma Pharmaceuticals Inc

1.210
0.0000.00%

자세한 내용은 Sonoma Pharmaceuticals Inc 회사

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Sonoma Pharmaceuticals Inc 정보

종목 코드 SNOA
회사 이름Sonoma Pharmaceuticals Inc
상장일Jan 26, 2007
CEOTrombly (Amy)
직원 수168
유형Ordinary Share
회계 연도 종료Jan 26
주소5445 Conestoga Court, Suite 150
도시BOULDER
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호80301
전화18007599305
웹사이트https://sonomapharma.com/
종목 코드 SNOA
상장일Jan 26, 2007
CEOTrombly (Amy)

Sonoma Pharmaceuticals Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--

자주 묻는 질문

Sonoma Pharmaceuticals Inc의 상위 5대 주주는 누구인가요?

Sonoma Pharmaceuticals Inc의 상위 5대 주주는 다음과 같습니다: Dr. Jay E. Birnbaum, Ph.D.

Sonoma Pharmaceuticals Inc(SNOA)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Sonoma Pharmaceuticals Inc의 주식을 보유한 기관은 총 40곳이며, 이들이 보유한 주식의 총 가치는 약 127.80K로 전체 발행 주식의 3.68%를 차지합니다. 이는 2025Q4 대비 -34692.00 증가한 수치입니다.

Sonoma Pharmaceuticals Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Sonoma Pharmaceuticals Inc의 Human Care 부문이 가장 높은 매출을 기록했으며, 금액은 3.86M로 전체 매출의 88.83%를 차지했습니다.